Australia's TGA Section 41HD Emergency Medical Device Import Approvals: Complete Guide for Healthcare Providers

Key Takeaways

• Section 41HD approvals allow emergency import of medical devices during supply shortages or disruptions in Australia
• Approvals are granted when ARTG-registered substitute devices are unavailable or in short supply
• Special exemptions come with specific conditions that sponsors must meet for import and supply authorization

---

TGA Provides Emergency Pathway for Medical Device Supply Disruptions

The Therapeutic Goods Administration (TGA) has established Section 41HD approvals under the Therapeutic Goods Act 1989 to address critical medical device supply emergencies in Australia. This regulatory mechanism enables sponsors to import and supply nominated medical devices under special exemption during supply disruption situations.

Emergency Approval Criteria

The TGA grants Section 41HD approvals when specific conditions are met regarding device availability. The primary criterion focuses on the unavailability or short supply of medical devices currently included in the Australian Register of Therapeutic Goods (ARTG) that could serve as substitutes.

Approvals may be issued when ARTG-registered devices that could act as alternatives are either currently unavailable, in short supply, or may reasonably become unavailable or experience supply shortages in the foreseeable future.

Regulatory Framework and Conditions

These emergency approvals operate under a structured framework that balances patient access with safety requirements. Sponsors receiving Section 41HD approvals must comply with specific conditions attached to their authorization, ensuring that imported devices meet appropriate safety and efficacy standards despite the expedited process.

The approval mechanism serves as a critical safety net for Australia’s healthcare system, particularly during global supply chain disruptions, manufacturing issues, or unexpected demand surges that could compromise patient care.

Impact on Healthcare Access

Section 41HD approvals represent a proactive approach to maintaining continuity of care during medical device shortages. This regulatory tool helps prevent treatment delays and ensures healthcare providers can access necessary medical devices even when primary suppliers face disruptions.

The framework demonstrates Australia’s commitment to adaptive regulatory responses that prioritize patient welfare while maintaining appropriate oversight of medical device safety and quality standards.

---

Frequently Asked Questions

What types of medical devices qualify for Section 41HD approvals?

Any medical device can potentially qualify if ARTG-registered substitute devices are unavailable or in short supply, and the situation constitutes a supply emergency that could impact patient care.

How long does the Section 41HD approval process take?

The TGA processes emergency applications expeditiously given the urgent nature of supply disruptions, though specific timeframes depend on the complexity of the application and supporting documentation provided.

What conditions are typically attached to Section 41HD approvals?

Conditions vary by device and situation but typically include safety monitoring requirements, supply limitations, reporting obligations, and specific distribution or use restrictions to ensure patient safety.

Related coverage

• A Decade of AI Medical Device Regulation: Key Updates for Pharma
• TGA Australia drug approval pharmaceutical: what the regulator is
• NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access